OLLIERA Trademark

Trademark Overview


On Friday, August 4, 2017, a trademark application was filed for OLLIERA with the United States Patent and Trademark Office. The USPTO has given the OLLIERA trademark a serial number of 87556742. The federal status of this trademark filing is REGISTERED as of Tuesday, April 3, 2018. This trademark is owned by Glaxo Group Limited. The OLLIERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
olliera

General Information


Serial Number87556742
Word MarkOLLIERA
Filing DateFriday, August 4, 2017
Status700 - REGISTERED
Status DateTuesday, April 3, 2018
Registration Number5436774
Registration DateTuesday, April 3, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 9, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 7, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, December 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, December 7, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, December 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 6, 2017ASSIGNED TO LIE
Wednesday, November 15, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 8, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 8, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, November 8, 2017SUSPENSION LETTER WRITTEN
Thursday, November 2, 2017ASSIGNED TO EXAMINER
Wednesday, August 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 8, 2017NEW APPLICATION ENTERED